Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy

Hal B. Jenson, Charles J. Gauntt, Kirk A. Easley, Jane Pitt, Steven E Lipshultz, Kenneth McIntosh, Jonnagadda S Rao

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In a matched case-control study of the association between coxsackieviruses and cardiac impairment, 24 human immunodeficiency virus (HIV) type 1-infected children with cardiac impairment were compared with 24 HIV-1-infected control subjects. Serologic evidence of coxsackievirus infection was present in all children, with no significant difference in geometric mean antibody titers between case patients and control subjects. Conditional logistic regression to test for an association between coxsackievirus antibody titer and the presence or absence of cardiac impairment, by any indicator, showed an odds ratio of 1.11 (95% confidence interval, 0.58-2.10; P = .75), indicating no association between coxsackievirus infection and cardiac impairment. Coxsackievirus antibody titers correlated positively with total IgG levels in nonrapid progressors but not in rapid progressors. Paired serum samples taken before and after diagnosis of cardiac impairment in 5 patients showed no evidence of intervening coxsackievirus infection. These results do not identify a causal role for coxsackieviruses for cardiomyopathy in HIV-1-infected children.

Original languageEnglish
Pages (from-to)1798-1802
Number of pages5
JournalJournal of Infectious Diseases
Volume185
Issue number12
DOIs
StatePublished - Jun 15 2002
Externally publishedYes

Fingerprint

Coxsackievirus Infections
Enterovirus
Cardiomyopathies
HIV-1
Antibodies
Case-Control Studies
Immunoglobulin G
Logistic Models
Odds Ratio
Confidence Intervals
Serum

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy. / Jenson, Hal B.; Gauntt, Charles J.; Easley, Kirk A.; Pitt, Jane; Lipshultz, Steven E; McIntosh, Kenneth; Rao, Jonnagadda S.

In: Journal of Infectious Diseases, Vol. 185, No. 12, 15.06.2002, p. 1798-1802.

Research output: Contribution to journalArticle

Jenson, Hal B. ; Gauntt, Charles J. ; Easley, Kirk A. ; Pitt, Jane ; Lipshultz, Steven E ; McIntosh, Kenneth ; Rao, Jonnagadda S. / Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy. In: Journal of Infectious Diseases. 2002 ; Vol. 185, No. 12. pp. 1798-1802.
@article{47570f6023174ebeb32273ca32e6e248,
title = "Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy",
abstract = "In a matched case-control study of the association between coxsackieviruses and cardiac impairment, 24 human immunodeficiency virus (HIV) type 1-infected children with cardiac impairment were compared with 24 HIV-1-infected control subjects. Serologic evidence of coxsackievirus infection was present in all children, with no significant difference in geometric mean antibody titers between case patients and control subjects. Conditional logistic regression to test for an association between coxsackievirus antibody titer and the presence or absence of cardiac impairment, by any indicator, showed an odds ratio of 1.11 (95{\%} confidence interval, 0.58-2.10; P = .75), indicating no association between coxsackievirus infection and cardiac impairment. Coxsackievirus antibody titers correlated positively with total IgG levels in nonrapid progressors but not in rapid progressors. Paired serum samples taken before and after diagnosis of cardiac impairment in 5 patients showed no evidence of intervening coxsackievirus infection. These results do not identify a causal role for coxsackieviruses for cardiomyopathy in HIV-1-infected children.",
author = "Jenson, {Hal B.} and Gauntt, {Charles J.} and Easley, {Kirk A.} and Jane Pitt and Lipshultz, {Steven E} and Kenneth McIntosh and Rao, {Jonnagadda S}",
year = "2002",
month = "6",
day = "15",
doi = "10.1086/340819",
language = "English",
volume = "185",
pages = "1798--1802",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy

AU - Jenson, Hal B.

AU - Gauntt, Charles J.

AU - Easley, Kirk A.

AU - Pitt, Jane

AU - Lipshultz, Steven E

AU - McIntosh, Kenneth

AU - Rao, Jonnagadda S

PY - 2002/6/15

Y1 - 2002/6/15

N2 - In a matched case-control study of the association between coxsackieviruses and cardiac impairment, 24 human immunodeficiency virus (HIV) type 1-infected children with cardiac impairment were compared with 24 HIV-1-infected control subjects. Serologic evidence of coxsackievirus infection was present in all children, with no significant difference in geometric mean antibody titers between case patients and control subjects. Conditional logistic regression to test for an association between coxsackievirus antibody titer and the presence or absence of cardiac impairment, by any indicator, showed an odds ratio of 1.11 (95% confidence interval, 0.58-2.10; P = .75), indicating no association between coxsackievirus infection and cardiac impairment. Coxsackievirus antibody titers correlated positively with total IgG levels in nonrapid progressors but not in rapid progressors. Paired serum samples taken before and after diagnosis of cardiac impairment in 5 patients showed no evidence of intervening coxsackievirus infection. These results do not identify a causal role for coxsackieviruses for cardiomyopathy in HIV-1-infected children.

AB - In a matched case-control study of the association between coxsackieviruses and cardiac impairment, 24 human immunodeficiency virus (HIV) type 1-infected children with cardiac impairment were compared with 24 HIV-1-infected control subjects. Serologic evidence of coxsackievirus infection was present in all children, with no significant difference in geometric mean antibody titers between case patients and control subjects. Conditional logistic regression to test for an association between coxsackievirus antibody titer and the presence or absence of cardiac impairment, by any indicator, showed an odds ratio of 1.11 (95% confidence interval, 0.58-2.10; P = .75), indicating no association between coxsackievirus infection and cardiac impairment. Coxsackievirus antibody titers correlated positively with total IgG levels in nonrapid progressors but not in rapid progressors. Paired serum samples taken before and after diagnosis of cardiac impairment in 5 patients showed no evidence of intervening coxsackievirus infection. These results do not identify a causal role for coxsackieviruses for cardiomyopathy in HIV-1-infected children.

UR - http://www.scopus.com/inward/record.url?scp=0037097545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037097545&partnerID=8YFLogxK

U2 - 10.1086/340819

DO - 10.1086/340819

M3 - Article

C2 - 12085328

AN - SCOPUS:0037097545

VL - 185

SP - 1798

EP - 1802

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -